Recurrence and Factors Associated with Recurrence in Dupuytren's Disease Patients Treated with Percutaneous Needle Aponeurotomy

dc.contributor.authorKoroglu, Muhammed
dc.contributor.authorErtem, Kadir
dc.contributor.authorOzdemir, Ekrem
dc.contributor.authorTaskiran, Gultekin
dc.contributor.authorKarakaplan, Mustafa
dc.contributor.authorErgen, Emre
dc.contributor.authorCicek, Ipek Balikci
dc.date.accessioned2026-04-04T13:30:41Z
dc.date.available2026-04-04T13:30:41Z
dc.date.issued2024
dc.departmentİnönü Üniversitesi
dc.description.abstractObjective: Dupuytren>s disease (DD) is a progressive condition of the palmar fascia that limits finger extension. Percutaneous needle aponeurotomy has become increasingly popular in recent years. Despite appropriate treatment, recurrence is common. This study investigates recurrence development following percutaneous needle aponeurotomy and evaluates the relationship between patient characteristics, disease-related factors, and recurrence in DD. Methods: This retrospective study included 98 fingers from 41 patients diagnosed with Dupuytren>s disease who underwent percutaneous needle aponeurotomy at a hand surgery outpatient clinic between 2012 and 2022. Patient records were reviewed, and characteristics such as age, gender, occupation, and dominant hand were documented. The stage of DD was determined preoperatively. Functional outcomes were assessed using a subjective satisfaction scale, and postoperative complications and recurrences were analyzed. Results: Of the 41 patients, 32 (78%) were male and 9 (22%) were female. The mean age was 62 years (range, 44-82 years), and the mean follow-up period was 45 months (range, 9-138 months). Postoperative evaluations showed that 17 patients (41.5%) had excellent results, 19 patients (46.3%) had good results, and 5 patients (12.2%) had fair results. Recurrence of Dupuytren>s disease occurred in 24 (58.5%) patients. Among all patients, 30 (73.2%) were willing to undergo reoperation, regardless of recurrence. The recurrence rate was significantly lower after percutaneous needle release in stage 1 DD (p = 0.011). Conclusion: Percutaneous needle aponeurotomy offers high patient satisfaction and early discharge benefits, making it a preferred option for surgeons, despite the potential for recurrence. While the classification of recurrence as a complication is debated, it is a recognized outcome of progressive DD. Regardless of patient characteristics, performing percutaneous needle aponeurotomy at an early stage can significantly reduce recurrence rates.
dc.identifier.doi10.58600/eurjther2500
dc.identifier.endpage831
dc.identifier.issn2564-7784
dc.identifier.issn2564-7040
dc.identifier.issue6
dc.identifier.orcid0000-0001-6167-3952
dc.identifier.orcid0000-0002-6452-2401
dc.identifier.orcid0000-0002-8892-494X
dc.identifier.orcid0000-0002-3709-558X
dc.identifier.orcid0000-0003-4706-2308
dc.identifier.orcid0000-0001-9035-0319
dc.identifier.orcid0000-0001-6878-708X
dc.identifier.startpage823
dc.identifier.trdizinid1294043
dc.identifier.urihttps://doi.org/10.58600/eurjther2500
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1294043
dc.identifier.urihttps://hdl.handle.net/11616/108290
dc.identifier.volume30
dc.identifier.wosWOS:001415362500006
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherPera Yayincilik Hizmetleri
dc.relation.ispartofEuropean Journal of Therapeutics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250329
dc.subjectDupuytren
dc.subjectpercutaneous needle aponeurotomy
dc.subjectrecurrence
dc.titleRecurrence and Factors Associated with Recurrence in Dupuytren's Disease Patients Treated with Percutaneous Needle Aponeurotomy
dc.typeArticle

Dosyalar